Tissue Regenix Group (TRX) Competitors GBX 58 -1.00 (-1.69%) (As of 08:03 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider Trades TRX vs. NAK, EGI, IMG, EDG, MTA, NGR, RRS, NG, WPM, and IAGShould you be buying Tissue Regenix Group stock or one of its competitors? The main competitors of Tissue Regenix Group include Nakama Group plc (NAK.L) (NAK), (EGI.L) (EGI), 532753 (IMG.L) (IMG), 651814 (EDG.L) (EDG), ArcelorMittal (MTA), Nature Group (NGR), Randgold Resources (RRS), National Grid (NG), Wheaton Precious Metals (WPM), and International Consolidated Airlines Group (IAG). These companies are all part of the "precious metals" industry. Tissue Regenix Group vs. Nakama Group plc (NAK.L) (EGI.L) 532753 (IMG.L) 651814 (EDG.L) ArcelorMittal Nature Group Randgold Resources National Grid Wheaton Precious Metals International Consolidated Airlines Group Nakama Group plc (NAK.L) (LON:NAK) and Tissue Regenix Group (LON:TRX) are both small-cap industrials companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation, risk and community ranking. Is NAK or TRX more profitable? Nakama Group plc (NAK.L) has a net margin of 0.00% compared to Tissue Regenix Group's net margin of -3.46%. Nakama Group plc (NAK.L)'s return on equity of 0.00% beat Tissue Regenix Group's return on equity.Company Net Margins Return on Equity Return on Assets Nakama Group plc (NAK.L)N/A N/A N/A Tissue Regenix Group -3.46%-3.31%0.50% Does the MarketBeat Community believe in NAK or TRX? Nakama Group plc (NAK.L) received 61 more outperform votes than Tissue Regenix Group when rated by MarketBeat users. Likewise, 90.28% of users gave Nakama Group plc (NAK.L) an outperform vote while only 69.53% of users gave Tissue Regenix Group an outperform vote. CompanyUnderperformOutperformNakama Group plc (NAK.L)Outperform Votes22390.28% Underperform Votes249.72%Tissue Regenix GroupOutperform Votes16269.53% Underperform Votes7130.47% Do insiders & institutionals hold more shares of NAK or TRX? 37.0% of Tissue Regenix Group shares are owned by institutional investors. 47.3% of Tissue Regenix Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has better valuation & earnings, NAK or TRX? Nakama Group plc (NAK.L) has higher earnings, but lower revenue than Tissue Regenix Group. Tissue Regenix Group is trading at a lower price-to-earnings ratio than Nakama Group plc (NAK.L), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNakama Group plc (NAK.L)£8.09M0.18N/A-£0.20-6.13Tissue Regenix Group£31.80M1.30-£1.10M-£0.01-5,800.00 Does the media favor NAK or TRX? In the previous week, Nakama Group plc (NAK.L)'s average media sentiment score of 0.00 equaled Tissue Regenix Group'saverage media sentiment score. Company Overall Sentiment Nakama Group plc (NAK.L) Neutral Tissue Regenix Group Neutral SummaryTissue Regenix Group beats Nakama Group plc (NAK.L) on 6 of the 11 factors compared between the two stocks. Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Get Tissue Regenix Group News Delivered to You Automatically Sign up to receive the latest news and ratings for TRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRX vs. The Competition Export to ExcelMetricTissue Regenix GroupBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£41.31M£164.93M£5.07B£1.39BDividend Yield4.12%3.25%4.99%11.73%P/E Ratio-5,800.00329.4783.571,549.53Price / Sales1.3014,939.521,220.30209,150.30Price / Cash5.7011.6739.4632.93Price / Book1.357.116.932.80Net Income-£1.10M-£18.52M£119.12M£152.70M7 Day Performance-5.69%-0.29%-1.83%-0.55%1 Month Performance8.21%8.05%-3.64%7.05%1 Year Performance4.91%26.03%31.64%91.75% Tissue Regenix Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRXTissue Regenix GroupN/AGBX 58-1.7%N/A+4.7%£41.31M£31.80M-5,800.00120NAKNakama Group plc (NAK.L)N/AGBX 1.23+6.5%N/A+0.0%£1.44M£8.09M-6.1353Gap DownHigh Trading VolumeEGI(EGI.L)N/AN/AN/AN/A£0.00N/A0.006Gap DownHigh Trading VolumeIMG532753 (IMG.L)N/AN/AN/AN/A£0.00N/A0.005,360High Trading VolumeEDG651814 (EDG.L)N/AN/AN/AN/A£0.00N/A0.002,610MTAArcelorMittalN/AN/AN/AN/A£0.00N/A0.009High Trading VolumeNGRNature GroupN/AN/AN/AN/A£0.00N/A0.0010Gap UpRRSRandgold ResourcesN/AGBX 6,546+7,701,076.5%N/AN/A£0.00N/A0.0021,300Gap UpNGNational Grid1.3356 of 5 starsGBX 982.60-0.5%GBX 1,181.25+20.2%-2.8%£48.05B£19.85B1,796.0010High Trading VolumeWPMWheaton Precious Metals0.778 of 5 starsGBX 4,901.80-0.4%GBX 5,200+6.1%+36.2%£22.24B£1.13B5,106.0442Positive NewsIAGInternational Consolidated Airlines Group1.0614 of 5 starsGBX 244.80+0.9%GBX 225-8.1%+48.2%£12.00B£30.59B582.225,360High Trading Volume Related Companies and Tools Related Companies NAK Competitors EGI Competitors IMG Competitors EDG Competitors MTA Competitors NGR Competitors RRS Competitors NG Competitors WPM Competitors IAG Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:TRX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tissue Regenix Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tissue Regenix Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.